New pill helps smokers kick the habit in major trial
NCT ID NCT04576949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a pill called cytisinicline to help adults stop smoking. Over 800 daily smokers took the pill or a placebo for 6 or 12 weeks. The goal was to see if the pill helped them stay smoke-free, verified by breath tests. Results showed it was effective for quitting smoking.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Lexington
Lexington, Kentucky, 40509, United States
-
Alliance for Multispecialty Research, LLC
Coral Gables, Florida, 33134, United States
-
Alliance for Multispecialty Research, LLC
Wichita, Kansas, 67207, United States
-
Alliance for Multispecialty Research, LLC
New Orleans, Louisiana, 70119, United States
-
Alliance for Multispecialty Research, LLC
Kansas City, Missouri, 64114, United States
-
Alliance for Multispecialty Research, LLC
Las Vegas, Nevada, 89119, United States
-
Alliance for Multispecialty Research, LLC
Norfolk, Virginia, 23502, United States
-
Alliance for Multispecialty Research, LLC.
Mobile, Alabama, 36608, United States
-
Alliance for Multispecialty Research, LLC.
Knoxville, Tennessee, 37920, United States
-
Arizona State University
Phoenix, Arizona, 85044, United States
-
Clinical Research Atlanta
Atlanta, Georgia, 30281, United States
-
Coastal Carolina Research Center, Inc.
Mt. Pleasant, South Carolina, 29464, United States
-
FutureSearch Trials of Dallas, LP
Dallas, Texas, 75231, United States
-
M3 Wake Research, Inc.
Raleigh, North Carolina, 27612, United States
-
Massachusetts General Hospital - Clinical Genetic Research Facility
Boston, Massachusetts, 02114, United States
-
MediSphere Medical Research Center, LLC
Evansville, Indiana, 47714, United States
-
Rochester Clinical Research, Inc.
Rochester, New York, 14609, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- Talking it out: could a Conversation-Based approach curb smoking in future nurses?
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Free meds could boost quit rates in stroke survivors
- Can a phone app help Spanish-Speaking smokers kick the habit?